GS vs TSLA: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and Tesla, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
The Goldman Sachs Group, Inc. ยท Financial Services
$923.29
+25.9% upside to fair value
Med Conviction Grade C High Quality
VS
Tesla, Inc. ยท Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction Grade C
QuantHub Verdict
TSLA has more upside to fair value (+45.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric GS TSLA
Current Price $923.29 $372.11
Fair Value Estimate $1,162.79 $539.56
Upside to Fair Value +25.9% +45.0%
Market Cap $272.4B $1,469.7B
Forward P/E โ€” โ€”
EV / EBITDA 26.3x 121.7x
Price / Sales 2.3x 14.2x
Price / FCF โ€” 209.1x
Revenue Growth YoY +22.9% +25.5%
Gross Margin 57.3% 18.9%
Operating Margin 24.8% 4.2%
Return on Equity 17.0% 4.6%
Dividend Yield 1.95% 0%
FCF Yield โ€” 0.48%
Analyst Consensus Hold Hold
Investment Thesis
GS โ€” The Goldman Sachs Group, Inc.
Goldman Sachs is a global financial services firm operating four divisions: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management, with 46,200 full-time employees and a market cap of $272.38 billion at a current price of $923.29. The business quality is high because of its leading franchise in advisory, underwriting, and trading, evidenced by a 17.0% ROE, a 57.3% โ€ฆ
TSLA โ€” Tesla, Inc.
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell โ€ฆ
Accumulation Zones
Metric GS TSLA
Zone Low $872.09 $404.67
Zone High $988.37 $458.63
In Buy Zone? Yes Yes
โ† GS Research    TSLA Research โ†’    All Research